Presented in part at the 5th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion held May 27–30, 2009 in Dallas, TX, USA.
Experience With the Levitronix CentriMag in the Pediatric Population as a Bridge to Decision and Recovery
Article first published online: 28 OCT 2009
© 2009, Copyright the Authors. Journal compilation © 2009, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
Volume 33, Issue 11, pages 1002–1004, November 2009
How to Cite
Kouretas, P. C., Kaza, A. K., Burch, P. T., Witte, M. K., Clayson, S. E., Everitt, M. D. and Selzman, C. H. (2009), Experience With the Levitronix CentriMag in the Pediatric Population as a Bridge to Decision and Recovery. Artificial Organs, 33: 1002–1004. doi: 10.1111/j.1525-1594.2009.00952.x
- Issue published online: 23 NOV 2009
- Article first published online: 28 OCT 2009
- Received July 2009; revised August 2009.
- Heart transplantation;
- Ventricular assist device
Short-term mechanical circulatory support in the pediatric population with acute cardiac failure has traditionally been limited to extracorporeal membrane oxygenation given the limited availability of pediatric-sized pumps. The Levitronix CentriMag system (Thoratec Corporation, Pleasanton, CA, USA) offers expanded options for short-term support for this population. We report our experience with the successful use of the CentriMag in the pediatric population as a bridge to decision after postcardiotomy ventricular failure and as a bridge to recovery after heart transplantation. The first patient was bridged to a long-term HeartMate II (Thoratec Corporation) as a bridge to potential recovery. The second patient was supported after severe graft failure post heart transplantation, with a full recovery. The Levitronix CentriMag has proven to be a versatile, safe, and effective short-term circulatory support system for our pediatric patients.